Third Avenue Management LLC – SUPN history
- Issuer:
- Supernus Pharmaceuticals Inc
- Quarters tracked:
- 17 (Q2 2022 → Q2 2026)
- Current shares:
- 152,724
- Current value:
- $7.10M
- Peak shares:
- 189,493 (Q3 2024)
- Overall change:
- +6108%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q2 2026 | 152,724 | $7.10M | $46.51 | 0 | 0% |
| Q1 2026 | 152,724 | $7.89M | $51.69 | -36,769 | -19% |
| Q4 2025 | 189,493 | $9.42M | $49.70 | 0 | 0% |
| Q3 2025 | 189,493 | $9.10M | $48.04 | 0 | 0% |
| Q2 2025 | 189,493 | $5.97M | $31.52 | 0 | 0% |
| Q1 2025 | 189,493 | $6.21M | $32.75 | 0 | 0% |
| Q4 2024 | 189,493 | $6.85M | $36.16 | 0 | 0% |
| Q3 2024 | 189,493 | $5.91M | $31.18 | +375 | 0% |
| Q2 2024 | 189,118 | $5.06M | $26.75 | +29,401 | +18% |
| Q1 2024 | 159,717 | $5.45M | $34.11 | 0 | 0% |
| Q4 2023 | 159,717 | $4.62M | $28.94 | +43,168 | +37% |
| Q3 2023 | 116,549 | $3.27M | $28.08 | +49,487 | +74% |
| Q2 2023 | 67,062 | $2.02M | $30.06 | +64,602 | +2626% |
| Q1 2023 | 2,460 | $89K | $36.18 | 0 | 0% |
| Q4 2022 | 2,460 | $88K | $35.77 | 0 | 0% |
| Q3 2022 | 2,460 | $84K | $34.15 | 0 | 0% |
| Q2 2022 | 2,460 | $72K | $29.27 | — | NEW |